GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q4 2025
Top Holdings57 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
CVS HEALTH CORPORATION | 8.2M | $650.5M | 13.2% | $57.60 | +34.63% | 9 qtrssince 2023-Q4 | Unchanged 0 |
TEVA PHARMACEUTICAL-SP ADR | 16.7M | $521.8M | 10.6% | $14.80 | +111.69% | 9 qtrssince 2023-Q4 | Increased 61 |
GLOBAL PAYMENTS INC | 5.9M | $458.3M | 9.3% | $109.79 | -27.76% | 21 qtrssince 2020-Q4 | Increased 70 |
TENET HEALTHCARE CORP | 2M | $394.2M | 8.0% | $55.91 | +260.07% | 29 qtrssince 2018-Q4 | Decreased 0 |
AMAZON.COM INC | 909,270 | $209.9M | 4.3% | $192.55 | +20.76% | 12 qtrssince 2023-Q1 | Increased 74 |
ZOOMINFO TECHNOLOGIES INC | 20M | $203.5M | 4.1% | $10.59 | -5.32% | 7 qtrssince 2024-Q2 | Increased 61 |
ISHR IBX USD HIYLD CB ETF-UI | 1.8M | $142.9M | 2.9% | — | — | — | New — |
VIATRIS INC | 11.1M | $138M | 2.8% | $10.93 | +14.77% | 9 qtrssince 2023-Q4 | Increased 67 |
THERMO FISHER SCIENTIFIC INC | 223,947 | $129.8M | 2.6% | $442.58 | +31.83% | 3 qtrssince 2025-Q2 | Decreased 0 |
DXC TECHNOLOGY CO | 8.3M | $121.8M | 2.5% | $25.92 | -42.56% | 29 qtrssince 2018-Q4 | Decreased 0 |
DIGITALOCEAN HOLDINGS INC | 2M | $96.4M | 2.0% | $48.80 | 0.00% | 1 qtr | New 68 |
EXPEDIA GROUP INC | 321,625 | $91.1M | 1.9% | $119.61 | +166.27% | 14 qtrssince 2022-Q3 | Decreased 0 |
US FOODS HOLDING CORP | 1.1M | $85.7M | 1.7% | $46.16 | +64.46% | 17 qtrssince 2021-Q4 | Increased 50 |
ADVANCED MICRO DEVICES | 394,188 | $84.4M | 1.7% | $214.16 | 0.00% | 1 qtr | New 68 |
ZILLOW GROUP INC - C | 1.2M | $79.4M | 1.6% | $77.91 | -10.97% | 2 qtrssince 2025-Q3 | Increased 59 |
THE CIGNA GROUP | 279,367 | $76.9M | 1.6% | $244.71 | +11.21% | 29 qtrssince 2018-Q4 | Increased 64 |
CENTENE CORP | 1.9M | $76.4M | 1.6% | $40.05 | +2.74% | 2 qtrssince 2025-Q3 | Increased 75 |
KNIGHT-SWIFT TRANSPORTATION | 1.5M | $76.3M | 1.6% | $50.82 | +43.24% | 12 qtrssince 2023-Q1 | Increased 69 |
ELEMENT SOLUTIONS INC | 2.8M | $70.8M | 1.4% | $22.23 | +13.68% | 28 qtrssince 2019-Q1 | Increased 58 |
LIONSGATE STUDIOS CORP | 7.5M | $68.5M | 1.4% | $7.72 | +19.75% | 2 qtrssince 2025-Q3 | Increased 65 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.9B across 57 positions as of Q4 2025. Top holdings: CVS (13.2%), TEVA (10.6%), GPN (9.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.
Active quarter - 15 new positions, 14 exits, 24 increased. Top move: CNC (INCREASED, conviction 75). Portfolio: $4.9B across 57 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer